What is DSCSA?
The Drug Supply Chain Security Act (DSCSA) is Title II of the Drug Quality and Security Act (DQSA) that was signed into law on November 27, 2013. Its purpose is to increase safety throughout the pharmaceutical supply chain in the US by increasing the traceability of pharmaceutical products across pharmaceutical manufacturers, wholesalers and dispensers.
Implemented over the course of three key phases between November 2017 and November 2023, DSCSA preempts all state legislation regarding pharmaceutical pedigree and traceability. Excellis has deep experience of working with every segment of the supply chain across every possible use case.
How can you get DSCSA compliant?
The clock is ticking but using our proven end-to-end serialization compliance model, we can help ensure your business is fully DSCSA compliant – both now and in the future.
Or specialized DSCSA compliance services include:
- Ongoing education, training and regulatory updates
- GAP Analysis of current compliance solution (or lack thereof)
- Development of comprehensive Strategy, including User Requirements for enabling technology, Business Requirements for supply chain partners, To-Be Work Flows, Budgets, Resource Loads, and fully Integrated Project Plan (IPP) for implementation
- Identification and ROI Business Cases of potential value scenarios, including increased operational efficiencies and revenue generation opportunities
To discuss what DSCSA means for your business and how you can ensure you are compliant ahead of time, get in touch with us.
You can also attend our regular Global Track & Trace events or join one of our free monthly webinars in which Excellis subject matter experts discuss the key trends and regulatory changes affecting the industry.